Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Amlodipine Besylate And Atorvastatin Calcium Tablets
3/27/2014 9:27:42 AM
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10mg, 2.5/20mg, 2.5/40mg, 5/10mg, 5/20mg, 5/40mg, 5/80mg, 10/10mg, 10/20mg, 10/40mg and 10/80 mg a therapeutic equivalent generic version of CADUET® (amlodipine Besylate and atorvastatin calcium) tablets, in the US market on March 26, 2014, following the approval by the United States Food & Drug Administration (USFDA).
Help employers find you! Check out all the jobs and post your resume.
comments powered by